DeviceSpace.com
Medical Device and Diagnostics
News & Jobs
 
Search the Site
    
 
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login           Employers:  Register | Login  

Medical Device Companies | Diagnostic Companies | Organizations | Search Profiles
 Company Profile

 

Innate Pharma 

Grand Pré
119/121 Ancien Chemin De Cassis
Marseille      France
Phone: 33-0-4-96-19-05-50 Fax: 33-04-96-19-05-55


SEARCH JOBS










 Company News
Highlights From Innate Pharma (IPH.PA )'s R&D Update Today In New York 4/10/2014 7:42:56 AM    More...
Innate Pharma (IPH.PA ) : Start Of Cohort Expansion Of Phase I Trial With Lirilumab And Nivolumab In Selected Solid Tumors 3/31/2014 10:08:44 AM    More...
Innate Pharma (IPH.PA ): R&D Update On April 10, 2014 In New York 3/17/2014 9:05:10 AM    More...
Innate Pharma (IPH.PA ): Raises [Eur]20.3 Million In A Private Placement Subscribed Entirely By US-Based Specialist Investors 11/20/2013 9:02:18 AM    More...
Innate Pharma (IPH.PA ): Launch of IND-Enabling Studies for IPH4102 11/8/2013 9:38:29 AM    More...
Innate Pharma (IPH.PA ) Presents New Data for Proprietary Programs Targeting TLR3 and KIR3DL2 4/12/2013 9:22:19 AM    More...
Innate Pharma (IPH.PA ) Release: Annual Results for 2012: Significant Advance for Four Drug Candidates and Strong Cash Position 3/5/2013 9:24:25 AM    More...
Innate Pharma (IPH.PA ): Phase I Clinical Trial of IPH2102/BMS-986015 in Combination With Ipilimumab Announced 12/19/2012 8:45:39 AM    More...
Innate Pharma (IPH.PA ) (Euronext Paris: FR0010331421 - IPH): First Patient Treated in the EffiKIR Trial 12/17/2012 9:29:00 AM    More...
Bristol-Myers Squibb Company (BMY), Innate Pharma (IPH.PA ) Announce $465 Million Deal for an Investigational Immuno-Oncology Biologic; Innate to Receive $35 Million Upfront, Shares Soar 7/6/2011 12:53:26 PM    More...
1234